Loading...
 
Toggle Health Problems and D

Cancer - Bladder

Did you know?
  • People with high levels of Vitamin D are 25% less likely to get bladder cancer
  • Some cancers have have been proven to be prevented or treated by Vitamin D
  • Vitamin D has not yet been proven to treat bladder cancer.
  • However Vitamin D does relieve pain and reduce the amount of chemotherapy needed
          (More bladder cancer info below: 25 studies )

Learn how Vitamin D is essential for good health
  Watch a 5 minute video "Does Less Sun Mean more Disease?"
  Browse for other Health Problems and D in left column or here
  see also Supplementing and More in the menu at the top of every page
If you have a disease associated with low Vit D take Vit D
Raising your Vit D levels will substantially prevent other low-Vit D health problems
Proof that Vitamin D Works   Getting Vitamin D into your body

Is 50ng enough?   How to restore levels quickly  VitaminDWiki interview and transcript - Jan 2022
Books and Videos 225   Diseases which are related due to vitamin D deficiency
Reasons for low response to vitamin D   Why are doctors reluctant
Cancer studies include:   Breast 237   Colon 129   Lung 53   Prostate 96   Pancreatic 54   Skin 114
Colds and flu   Dark Skin 451   Diabetes 510   Obesity 394   Pregnancy 830   Seniors 384
COVID-19 treated by Vitamin D - studies, reports, videos

Bladder Cancer – June 2022

A prospective trial investigating the role of Serum 25-Hydroxyvitamin D in diagnosis and prognosis of bladder cancer
PLOS x Published: June 16, 2022 https://doi.org/10.1371/journal.pone.0266371
Ahmed Abdelgawad ,Abdelwahab Hashem,Ahmed Mosbah ,Laila A. Eissa

Image
Purpose
Higher levels of serum 25-hydroxyvitamin D 25(OHD) are associated with better prognosis in breast and colorectal cancer. However, the evidence is still inconclusive for bladder cancer (BC). Herein, we investigated the diagnosis and prognosis roles of serum levels of 25(OHD) in suspected BC patients presented by hematuria.

Methods
This prospective cohort study involved suspected patients of BC presented with hematuria. Patients were evaluated by CT urogram, office cystoscopy and urine cytology with subsequent inpatient biopsy for positive findings. Baseline blood samples were collected for measurement of 25(OHD) by electrochemiluminescence binding assay at the time of diagnosis. Patients with non-muscle-invasive BC (NMIBC) underwent transurethral resection of bladder tumor (TURBT) and adjuvant intravesical chemotherapy or BCG instillation. Patients were followed up for their recurrence status during 10 to 24 months. Recurrence was defined as the first time of NMIBC pathological relapse during the follow up period.

Results
A total of 115 patients were included in the final analysis. Patients had proven pathological BC (64 with NMIBC, and 20 with muscle invasive) and 31 patients were considered as control group. Controls were those patients with BC-free workup (including cytology, cystoscopy, and upper tract imaging). BC group showed a lower level of 25(OHD) than control group 16.47±5.88 versus 28.99±3.19 ng/mL (p<0.001). In addition, muscle invasive group also showed a lower level than NMIBC group 13.17±4.5 versus 17.49±5.04 ng/mL (P = 0.003). During the follow-up period of, tumor recurrence occurred in 16 (25%) of NMIBC patients. The baseline 25(OHD) were decreased in patients who experienced early recurrence; without being statistically significant (15.99 ± 5.17 vs. 18.38 ± 5.14 ng/mL; p = 0.08). 25(OHD) deficiency/insufficiency occurred in 5 (16.1%) and 64 (76.2%) in control and BC patients, respectively, (odds-ratios (OR): 2.13; 95% confidence intervals (CI), 1.52–2.99; P < 0.0001).

Conclusion
Serum 25(OHD) is significantly decreased in BC patients especially those with tumor muscle invasive group. However, the baseline serum 25(OHD) does not predict the recurrence in the NMIBC patients.
 Download the PDF from VitaminDWiki


All Bladder Cancer studies in VitminDwiki

See also All items in category Cancer and Vitamin D 249 items

See also web

  • Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort - June 2021 PDF
  • Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study - July 2020 https://doi.org/10.1080/01635581.2020.1737150
  • 5 out of 7 studies of Bladder Cancer and Vitamin D found an association Science Daily Nov 2016
  • LOW SERUM 25-HYDROXYVITAMIN D IS ASSOCIATED WITH INCREASED BLADDER CANCER RISK: A SYSTEMATIC REVIEW AND EVIDENCE OF A POTENTIAL MECHANISM - Jan 2019;
    "Low vitamin D levels were associated with bladder cancer risk in 5/6 of the studies"
    Bladder cells appear to need to activate Vitamin D locally, doi: 10.1016/j.jsbmb.2019.01.002

Attached files

ID Name Comment Uploaded Size Downloads
17937 Vitamin D-binding protein and risk of bladder cancer.pdf admin 23 Jun, 2022 02:00 456.84 Kb 33
17936 Bladder Cancer Table.jpg admin 23 Jun, 2022 01:47 67.10 Kb 98
17935 Bladder Cancer PLOS_CompressPdf.pdf PDF 2022 admin 23 Jun, 2022 01:47 285.78 Kb 37
See any problem with this page? Report it (WORKS NOV 2021)